Many enzymes assemble into defined oligomers, providing a mechanism for 8 cooperatively regulating enzyme activity. Recent studies in tissues, cells, and in vitro 9 have described a mode of regulation in which enzyme activity is modulated by 10 polymerization into large-scale filaments 1-5 . Enzyme polymerization is often driven by 11 binding to substrates, products, or allosteric regulators, and tunes enzyme activity by 12 locking the enzyme in high or low activity states 1-5 . Here, we describe a unique, 13 ultrasensitive form of polymerization-based regulation employed by human CTP 14 synthase 2 (CTPS2). High-resolution cryoEM structures of active and inhibited CTPS2 15 filaments reveal the molecular basis of this regulation. Rather than selectively stabilizing 16 a single conformational state, CTPS2 filaments dynamically switch between active and 17 inactive filament forms in response to changes in substrate and product levels. Linking 18 the conformational state of many CTPS2 subunits in a filament results in highly 19 cooperative regulation, greatly exceeding the limits of cooperativity for the CTPS2 20 tetramer alone. The structures also reveal a link between conformational state and 21 control of ammonia channeling between the enzyme's two active sites. This filament-22 based mechanism of enhanced cooperativity demonstrates how the widespread 23 phenomenon of enzyme polymerization can be adapted to achieve different regulatory 24 outcomes. 25 26 CTP synthase (CTPS) is the key regulatory enzyme in pyrimidine biosynthesis, with critical roles 27 in regulation of nucleotide balance 6 , maintenance of genome integrity 7,8 , and synthesis of 28 membrane phospholipids 9 . CTPS catalyzes the conversion of UTP to CTP in an ATP-dependent 29 process, the rate-limiting step in CTP synthesis. CTPS is regulated through feedback inhibition 30 by CTP binding, and is allosterically regulated by GTP, making it sensitive to levels of the four 31 essential ribonucleotides, reflecting its role as a critical regulatory node in nucleotide 32 metabolism 10-13 . CTPS is a homotetramer, with each monomer composed of a glutaminase and 33 an amidoligase domain connected by a helical linker 14 . Ammonia is generated from glutamine 34 then transfered to the amidoligase domain, where it is ligated to UTP to form CTP; while both of 35 these catalytic mechanisms are well understood, the mechanism of ammonia transfer between 36 the two separated active sites has not yet been described. Previously, we showed that CTPS 37 undergoes a conserved conformation cycle controlled by substrate and product binding, 38 involving two major structural changes: upon substrate binding, the glutaminase domain rotates 39 towards the amidoligase domain, bringing the two active sites closer, and the tetramer interface 40 rearranges to accommodate UTP binding 5 . 41
produced higher resolution structures at 3.5Å and 3.1Å of the S-state and P-state filaments, 70 respectively ( Fig. 1e, f, Supplementary Fig. 1a-d , Supplementary Table 1 ). Both CTPS2 71 filaments are composed of stacked tetramers, with a eukaryote-specific helical insert in the 72 glutaminase domain forming the interfaces between tetramers. The filament assembly 73 interactions are identical in both CTPS2 filament states (Cα RMSD 0.8 Å), and are the same as 74 the CTPS1 interface 5 (Cα RMSD 1.3 Å) ( Fig. 1g ). We previously showed that mutation of 75 conserved H355 at the filament interface completely abolishes CTPS1 polymerization 5 . This 76 mutation has the same effect on both S-and P-state CTPS2 polymerization (Fig. 1b ). However, 77 CTPS1 filaments have additional interactions between poorly ordered C-terminal tails of 78 adjacent tetramers 5 , which we did not observe in either CTPS2 filament ( Supplementary Fig. 1i ). 79
While the filament assembly interfaces are identical in both CTPS2 filament states, the 80 conformation of the enzyme and the helical symmetry are strikingly different. The S-state 81 CTPS2 and CTPS1 filaments are very similar at the level of monomer, tetramer, and filament 5 82 ( Fig. 1c ,e, Supplementary Fig. 1e-h) . By contrast, tetramers in the CTPS2 P-state filament are 83 in an inactive, CTP-inhibited conformation, similar to that observed in bacterial CTPS 84 homologs 5, 10, 14 (Fig. 1d,f, Supplementary Fig. 1e-h ). These differences in conformation result in 85 different helical architectures. The two domains of each protomer rotate relative to each other by 86 7° between the S-and P-states; the interactions at the interdomain interface remain fixed (Cα 87 RMSD 0.8 Å), with the rotation arising from flexing of residues 40-87 relative to the core of the 88 amidoligase domain ( Supplementary Fig. 2a-d) . The interdomain rotation alters the positions of 89 filament contacts around the helical axis, leading to a 14° difference in the helical rotation per 90 tetramer between the S-state and P-state filaments ( Fig. 1c,d,h ). Rare CTPS2 filaments 91 observed in the absence of nucleotides had S-state architecture in negative stain 92 reconstructions, suggesting this may be a somewhat more stable conformation of the enzyme 93 ( Supplementary Fig. 3 ). CTPS2 therefore assembles into active and inactive filaments with 94 unique architectures, depending on the ligand-binding and conformational state of constituent 95 tetramers, while maintaining a fixed filament interface. 96 97 Novel product binding in the P-state CTPS2 filament 98
The P-state CTPS2 filament structure revealed a novel ADP binding site. In all existing crystal 99 and cryoEM structures of CTPS homologs with adenine nucleotides bound, the adenine ring 100 binds to a pocket formed by R211 and the "lid" residues 238-244 5,10 . In S-state CTPS2 filaments 101 ATP is bound in the same position as in previous structures. By contrast, in the P-state CTPS2 102 filament, while the ADP phosphates are bound in the conventional position, the adenine base is reoriented by approximately 90 o towards the glutaminase domain, and packs in a new site 104 between residues N73 and F77 ( Fig. 2a-c ). This suggests that the adenine base can bind both 105 sites in CTPS2, and switches to the second site upon transition to the P-state. Furthermore, the 106 overlap between the ATP and ADP binding sites could allow ADP to act as an allosteric 107 regulator, similar to the allosteric regulation observed with CTP at the partially overlapping 108 UTP/CTP binding site. 109
The CTP-binding mode in the P-state filament structure is the same as that in existing 110 CTP-bound E. coli CTPS structures 5,10 : helix 224-234 is pulled towards CTP, with F233 packing 111 against the CTP base, producing a hydrogen-bonding network amongst residues E161, R164, 112 and H235 at the tetramerization interface ( Fig. 2d, e ). Consistent with this binding mode, 113 mutation of these residues has been shown to eliminate feedback inhibition of CTPS 1 , including 114 of CTPS1 in CHO cells that results in resistance to chemotherapeutic drugs 7 . 115 116
Substrate binding opens a tunnel in the CTPS monomer 117
The S-state CTPS2 filament structure is the first near-atomic resolution structure of any CTPS in 118 the substrate-bound conformation, providing insight into the mechanism of ammonia transfer 119 between the two active sites. Previous studies have identified a putative ~25 Å tunnel required 120 to facilitate ammonia transfer between the glutaminase and amidoligase active sites 14, 24 (Fig. 3 ). 121
However, in the P-state CTPS2 structure as well as existing P-state bacterial structures, this 122 tunnel is blocked by a constriction formed by conserved residues V58, P52, and H55 (V60, P54, 123 and H57 in E. coli) 14 (Fig. 3a , c, Supplementary Fig. 4a , c). Based on a crystal structure of E. 124 coli CTPS, Endrizzi et al. 14 predicted that H57 may act as a "gate" at the exit of the ammonia 125 tunnel, with UTP binding altering the orientation of H57, causing the gate to open. Indeed, in the 126 S-state CTPS2 filament, H55 reorients to interact with the UTP base, pulling loop P52-V58 127 towards the amidoligase active site ( Fig. 3b, d , Supplementary Fig. 4b, d ) (Supplementary Video 128 1). This conformational change opens the H55 gate and relieves the P52-V58 constriction, 129 providing a tunnel with a nearly uniform ~4 Å diameter for ammonia transfer between the two 130 active sites ( Fig. 3e-h ). This structural coupling of substrate binding with opening of the 131 ammonia tunnel likely provides the mechanistic basis for the observed coupling of the two 132 enzymatic activities of CTPS, which ensures ammonia is only released into the active site when 133 a UTP substrate is present to accept it 25 . 134 135 136
Regulation of CTPS2 filaments is highly cooperative 138
Given that the filament interface is identical in the S-state and P-state structures, we 139 hypothesized that CTPS2 filaments could directly switch between the S-state and P-states while 140 remaining polymerized, perhaps allowing for coordinated conformational changes along entire 141 filaments. To test this hypothesis, we trapped CTPS2 in filaments by engineering cysteine 142 disulfide crosslinks at the filament interface, yielding the CTPS2 CC mutant (Fig. 4a, b , 143 Supplementary Fig. 5 ). In the absence of ligands CTPS2 CC spontaneously and robustly 144 polymerized into filaments under non-reducing conditions (Fig. 4c ). We generated 2D averages 145 of crosslinked CTPS2 CC in different ligand states to probe for conformational changes within the 146 filaments. Because their different helical symmetries give rise to a characteristic ~180 o repeated 147 view every 300 Å (S-state) or 400 Å (P-state), the different architectures are readily 148 distinguishable in 2D averages ( Fig. 4d ). Classification and alignment of 2D averages to low-149 pass filtered projections of the CTPS2 structures revealed that apo CTPS2 CC filaments had S-150 state architecture and transitioned to the P-state upon addition of CTP, confirming that 151 conformational switching within intact filaments is possible ( Fig. 4e ) (Supplementary Video 2). 152
We suspected that linking the conformational state of many CTPS2 subunits within a 153 filament could lead to enhanced cooperativity in CTPS2 regulation. We therefore compared the 154 UTP and CTP kinetic parameters of CTPS2 filaments with those of the CTPS2-H355A non-155 polymerizing mutant ( Fig. 5, Supplementary Fig. 6 ). Unlike CTPS1 5 , polymerization did not 156 increase the V max of CTPS2 ( Fig. 5a ). Further, CTPS2 filaments and CTPS2-H355A 157 homotetramers exhibited nearly identical S 0.5 and IC 50 values for UTP and CTP 158 Supplementary Table 2 ). CTPS2-H355A inhibition is highly cooperative, with n Hill of 3.5 that 159 approaches the theoretical limit for a tetramer (Fig. 5c ). CTPS kinetic parameters reported for 160 various species vary significantly, but hill coefficients close to 4 have been reported for both 161 activation and inhibition 26, 27 . Remarkably, CTPS2 filaments exhibited an even higher n Hill of 8.3, 162 providing a switch-like response to changes in CTP concentrations ( Fig. 5c ). Dilution of wild-163 type CTPS2 below its critical concentration for assembly caused disassembly into tetramers and 164 occasional short filaments, resulting in a n Hill of 3.9, similar to that observed for the non-165 polymerizing mutant ( Fig. 5d , f). Polymerization therefore greatly increases the cooperativity of 166 CTPS2 regulation, likely due to concerted conformational changes within filaments ( Fig. 5h ). Given that the residues involved in filament assembly interactions are completely conserved 174 between CTPS1 and CTPS2, it is intriguing that CTPS1 forms S-state but not P-state filaments 5 . 175
It is possible that product-bound CTPS1 adopts a unique conformation incompatible with 176 filament assembly. Alternatively, the contact between disordered C-terminal regions observed in 177 CTPS1 5 but not CTPS2 may play a role in differential assembly regulation; the C-terminus 178 regulates CTPS2 activity in a phosphorylation-dependent manner and accounts for much of the 179 sequence variation between isoforms 28,29 . Differences in the regulatory role of filaments 180 between CTPS1 and CTPS2 may reflect their different physiological roles: consistent with its 181 role in cellular proliferation during the immune response CTPS1 may be induced into filaments 182 which reduce sensitivity to feedback inhibition and allow expansion of CTP pools to meet 183 increased demand, whereas under more homeostatic conditions the extreme sensitivity of 184 CTPS2 fiilaments may help maintain a strictly defined UTP/CTP balance. 185
Cooperativity in biological systems often arises from the association of protein subunits 186 into oligomeric complexes, allowing for coordinated regulation through coupling of 187 conformational states. Typically, cooperativity is associated with assemblies of relatively few 188 protein subunits, with hemoglobin tetramers providing a canonical example. Large protein 189 arrays and polymers hold the potential for massive cooperativity, with conformational 190 information integrated across hundreds or thousands of protein subunits [30] [31] [32] to increased mutagenesis, sensitization to DNA damaging agents, and multidrug resistance 37,38 . 200 Many enzymes in a broad range of metabolic pathways form filamentous polymers 19,21,39-201 42 . In the few examples that have been biochemically and structurally characterized to date, 202 enzyme regulation arises from assembling filaments that stabilize particlular conformational 203 states 1-5 . The enhanced cooperativity of CTPS2 is a novel filament-based mechanism of 204 enzyme regulation, which likely serves to stabilize nucleotide levels over a narrow concentration 205 range. This new function for metabolic filaments highlights the diversity of ways in which self-206 assembly can be adapted to allosterically fine-tune enzyme regulation and improve the 207 efficiency of metabolic control. 208 209 Acknowledgments 210
We thank G. Carman (Rutgers University) for the hCTPS2-expressing S. cerevisiae strain. We In GHY56, both endogenous Saccharomyces cerevisiae CTP synthase genes URA7 and URA8 235 are deleted. This lethal deletion is rescued by plasmid pDO105-CTPS2, which directs 236 expression of C-terminally His 6 -tagged CTPS2 from the ADH1 promoter. GHY56 cells were 237 grown in 4X YPD at 30 o C, harvested by centrifugation, frozen as droplets in liquid nitrogen, and 238 then ground into powder while frozen. Cell powder (~20g) was resuspended in lysis buffer (50 239 mM Tris-HCl, 200 mM NaCl, 0.3M sucrose, 20 mM imidazole, pH 8.0), and centrifuged at 240 14,000 RPM for 40 minutes at 4 o C in a Thermo Scientific Fiberlite F14-14 × 50cy rotor. Clarified 241 lysate was loaded onto a 5 mL HisTrap FF Crude column (GE) on an ÄKTA Start 242 chromatography system (GE) pre-equilibrated in column buffer (20 mM Tris-HCl, 0.5M NaCl, 45 243 mM imidazole, 10% glycerol, pH 7.9). The column was washed with 25 column volumes (CV) of 244 column buffer, and CTPS2 was eluted with 5CV of elution buffer (20 mM Tris-HCl, 0.5M NaCl, 245 250 mM imidazole, 10% glycerol, pH 7.9) as 1 mL fractions. Fractions containing CTPS2 were 246 pooled and dialyzed into storage buffer (20 mM Tris-HCl, 0.5M NaCl, 10% glycerol, 7 mM β-247 mercaptoethanol, pH 7.9) using Snakeskin 3500 MWCO dialysis tubing (Thermo Scientific). 248
Dialyzed CTPS2 was then concentration approximately 5-fold using a 3 kDa cut-off centrifugal 249 filter unit (Millipore), flash-frozen in liquid nitrogen, and stored at -80 o C. CTPS2 mutants were 250 purified using the same methods. 251 252
Cloning of mutants 253
CTPS2-H355A and CTPS2 CC mutants were generated using the Gibson assembly method 44 . 254 PCR was used to amplify two separate fragments of the pDO105-CTPS2 plasmid backbone 255 flanking the mutation site, which were then ligated together with ~60 base pair DNA fragments 256 containing the desired H355A or V352C mutations. Mutations were confirmed by Sanger 257 sequencing. 258 259
Negative-stain electron microscopy 260
Prior to imaging, CTPS2 in storage buffer was exchanged into imaging buffer (20 mM Tris-HCl, 261 100 mM NaCl, 7 mM β-mercaptoethanol, pH 7.9) using a 7K MWCO Zeba Spin Desalting 262 Column (Thermo Scientific). For imaging CTPS2 CC disulfide crosslinked filaments, protein was 263 exchanged into non-reducing buffer (20 mM Tris-HCl, 100 mM NaCl, pH 7.9). 100 mM DTT was 264 added to depolymerize CTPS2 CC filaments. CTPS2 was applied to glow-discharged carbon-265 coated grids, stained with 0.7% uranyl formate, and imaged on a Tecnai G2 Spirit (FEI co.) 266 operating at 120 kV. Images were acquired at 67,000× magnification on a US4000 4k × 4k CCD 267 camera (Gatan, Inc.). 268 269
Negative-stain electron microscopy image processing and reconstructions 270
3D reconstruction of Apo CTPS2 filaments was performed using iterative helical real space 271 reconstruction (IHRSR) 45, 46 in SPIDER, with hsearch_lorentz 47 used to refine helical symmetry 272 parameters, and with D2 point-group symmetry enforced. Cryo-EM structures of S-state or P-273 state CTPS2 filaments low-pass filtered to 40Å were used as starting models. 2D class 274 averages of CTPS2 CC were generated by manually picking particles and performing 2D 275 classification in Relion 48 . CTPS2 CC class averages were aligned to 30Å low-pass filtered 276 projections of the S-state and P-state cryoEM structures using e2classvsproj.py in EMAN2 49 . 277 278
Cryo-electron microscopy 279
Cryo-EM samples were prepared by applying CTPS2 to glow-discharged CFLAT 1.2/1.3 holey-280 carbon grids (Protochips Inc.), blotting with a Vitrobot (FEI co.), and plunging into liquid ethane. 281 CTPS2 was exchanged into imaging buffer and incubated with nucleotides for 5 minutes at 282 37 o C before preparing cryo-EM samples. Conditions for the S-state filament structure were 7 283 µM CTPS2, 2 mM UTP, 2 mM ATP, 0.2 mM GTP, and 10 mM MgCl 2 . Conditions for the P-state 284 filament structure were 8 µM CTPS2, 2 mM CTP, 2 mM ADP, and 10 mM MgCl 2 . Data for 285 preliminary 3D reconstructions was collected on a Tecnai G2 F20 (FEI co.) operating at 200 kV. 286
Movies were acquired on a K-2 Summit Direct Detect camera in counting mode with a pixel size 287 of 1.26 Å/pixel, collecting 36 frames with a total dose of 45 electrons/Å 2 , with a defocus range of 288 -1.0 to -2.5 µm. Data for high-resolution structures was collected on a Titan Krios (FEI co.) 289 equiped with a Quantum GIF energy filter (Gatan Inc.) operating in zero-loss mode with a 20 eV 290 slit width. Movies were acquired on a K-2 Summit Direct Detect camera in super-resolution 291 mode with a pixel size of 0.525 Å/pixel, collecting 50 frames with a total dose of 90 electrons/Å 2 . 292
Movies were collected within a defocus range of -1.0 to -2.5 µm. EPU (FEI co.) and Leginon 50 293 software were used for automated data collection. 294 295
Cryo-electron microscopy image processing and reconstructions 296
Movie frame alignment and dose-weighting was performed using MotionCor2 51 , and CTF 297 parameters were estimated using GCTF 52 . For data collected on the Tecnai G2 F20, particles 298 were picked manually using Appion 53 . 3D reconstructions at ~8Å resolution were generated 299 using IHRSR 45, 46 in SPIDER, using cylinders as starting models and imposing D2 symmetry, 300 with helical symmetry refined using hsearch_lorentz 47 . For Titan Krios data, particles were 301 initially picked manually from a subset of images, and used to generate 2D averages in Relion 48 . 302
These initial 2D averages were used as templates for Relion automated picking from all images. 303 2D classification in Relion was used to remove poorliy aligning particle picks, and well-defined 304 particles were then subject to Relion auto-refinement, using the SPIDER reconstructions low-305 pass filtered to 30Å as starting models. D2 symmetry was imposed during all 3D refinement. 306
Parameters, particles, and structures from Relion auto-refine were exported to cisTEM 54 , where 307 multiple further rounds of 2D and 3D classification were performed. Final reconstructions of S-308 state and P-state CTPS2 filaments were generated in cisTEM, using automatic refinement, 309 followed by manual refinement with CTF refinement implemented. Maps were sharpened in 310 cisTEM using a b-factor of 50 Å 2 . Resolutions were estimated using the FSC 0.143 cutoff. Details 311 of 3D reconstructions are summarized in Supplementary Table 1 . 312 313 Model building 314 MODELLER 55 was used to generate an initial homology model of the full-length CTPS2 315 monomer, using partial crystal structures of the CTPS2 glutaminase (PDB 2V4U) and 316 amidoligase domains (PDB 2VO1) aligned to a crystal structure of the full-length E. Coli CTPS 317 monomer (PDB 2AD5). The CTPS2 glutaminase, amidoligase, and linker domains were fit 318 individually as rigid bodies into EM maps using Chimera. Structures were then refined using 319 multiple cycles of real-space refinement in Phenix 56 and Coot 57 . 320 321 Tunnel modelling 322 CAVER Analyst 58 software was used to model tunnels through the CTPS2 atomic models. The 323 same starting coordinates were used for the S-state and P-state filaments, at a site adjacent to 324 the glutaminase domain catalytic cysteine 399. Probe radii of 0.5Å and 1.5Å were used for the P 325 and S-state structures, respectively, and other tunnel computation parameters were set to 326 default values. The use of a less restrictive, smaller probe radius for the inhibited state allowed 327 us to define a continuous tunnel through the constriction points. Plots of tunnel diameter versus 328 distance were also produced in CAVER Analyst. 329
330

CTPS2 kinetics 331
Kinetic parameters for CTPS2 and CTPS2-H355A were determined using the ADP-Glo assay 332 (Promega), using similar conditions to those described by Sakamoto et al 59 . Assays were 333 performed in 50 mM K-HEPES, 5 mM KCl, 0.01% tween 20, 0.01% BSA, 20 mM MgCl 2 , pH 334 8.0. All steps of the assay were performed at room temperature in black, low volume 384 well 335 plates (Corning). UTP kinetic assays were performed with 1500 nM CTPS2, 0-150 µM UTP, 500 336 µM ATP, 5 µM GTP, and 500 µM Glutamine. CTP inhibition assays were performed with 300 337 nM or 1500 nM CTPS2, 0-70 µM CTP, 100 µM UTP, 100 µM ATP, 5 µM GTP, and 100 µM 338
Glutamine. The total volume of the CTPS2 assays was 6 µl, and reactions were ran for 60 339 minutes (300 nM CTPS2) or 12 minutes (1500 nM CTPS2). CTPS2 reactions were terminated 340 by addition of 6 µl ADP-Glo reagent and incubated for 1 hour, after which 12 µl of kinase 341 
